ITRM
ITRM
NASDAQ · Pharmaceuticals

Iterum Therapeutics Plc

$0.17
0.00 (-1.35%)
As of Mar 24, 10:13 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +14,214.7% upside
Low Target $15.49
Average Target $24.02
High Target $28.73
Current Price $0.17
Current
$0.17
Target
$24.02
$15.49 $24.02 avg $28.73
Scenario Analysis
Bear Case
$15.49
9,131.2%
Low target
Base Case
$24.02
+14,214.7%
Avg target
Bull Case
$28.73
+17,021.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.50
-88.8% from high
52-Week Low
$0.14
+23.7% from low
Target vs 52W High
$24.02
+1,501.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%